Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4080

1.

Practical approach to the patient with acute neuromuscular weakness.

Nayak R.

World J Clin Cases. 2017 Jul 16;5(7):270-279. doi: 10.12998/wjcc.v5.i7.270. Review.

2.

Concomitant Transverse Myelitis and Acute Axonal Sensory-Motor Neuropathy in an Elderly Patient.

Oliveira LM, Cury RG, Castro LH, Nitrini R.

Case Reports Immunol. 2017;2017:7289474. doi: 10.1155/2017/7289474. Epub 2017 Jul 13.

3.

Immune mediated neuropathy following checkpoint immunotherapy.

Gu Y, Menzies AM, Long GV, Fernando SL, Herkes G.

J Clin Neurosci. 2017 Jul 29. pii: S0967-5868(16)31194-8. doi: 10.1016/j.jocn.2017.07.014. [Epub ahead of print] Review.

PMID:
28765062
4.

Clinical and electrophysiological features of post-traumatic Guillain-Barré syndrome.

Li X, Xiao J, Ding Y, Xu J, Li C, He Y, Zhai H, Xie B, Hao J.

BMC Neurol. 2017 Jul 27;17(1):142. doi: 10.1186/s12883-017-0919-x.

5.

Neurological Complications during Treatment of Middle East Respiratory Syndrome.

Kim JE, Heo JH, Kim HO, Song SH, Park SS, Park TH, Ahn JY, Kim MK, Choi JP.

J Clin Neurol. 2017 Jul;13(3):227-233. doi: 10.3988/jcn.2017.13.3.227.

6.

Rapid Assessment Zika Virus Knowledge Among Clinical Specialists in Singapore: A Cross-sectional Survey.

Yung CF, Tam CC, Rajadurai VS, Chan JK, Low MS, Ng YH, Thoon KC, Tan LK.

PLoS Curr. 2017 May 3;9. pii: ecurrents.outbreaks.44b19196298e01f3a6dcd4c09f235fa8. doi: 10.1371/currents.outbreaks.44b19196298e01f3a6dcd4c09f235fa8.

7.

Clinical association: Lyme disease and Guillain-Barre syndrome.

Patel K, Shah S, Subedi D.

Am J Emerg Med. 2017 Jul 8. pii: S0735-6757(17)30559-4. doi: 10.1016/j.ajem.2017.07.030. [Epub ahead of print]

PMID:
28711274
8.

Unusual sensory variant of Guillain-Barré syndrome.

Semproni M, Gibson G, Kuyper L, Tam P.

BMJ Case Rep. 2017 Jul 14;2017. pii: bcr-2016-218935. doi: 10.1136/bcr-2016-218935.

PMID:
28710191
9.

Guillain-Barre Syndrome in Postpartum Period: Rehabilitation Issues and Outcome - Three Case Reports.

Gupta A, Patil M, Khanna M, Krishnan R, Taly AB.

J Neurosci Rural Pract. 2017 Jul-Sep;8(3):475-477. doi: 10.4103/jnrp.jnrp_474_16.

10.

In vitro susceptibility of geographically and temporally distinct zika viruses to favipiravir and ribavirin.

Baz M, Goyette N, Griffin BD, Kobinger GP, Boivin G.

Antivir Ther. 2017 Jul 11. doi: 10.3851/IMP3180. [Epub ahead of print]

PMID:
28694390
11.

Neuropsychiatric debut as a presentation of Guillain-Barré Syndrome: An atypical clinical case and literature review.

Sangroula D, Durrance R, Bhattarai S, Nandakumar T.

J Clin Neurosci. 2017 Jul 5. pii: S0967-5868(17)30678-1. doi: 10.1016/j.jocn.2017.06.041. [Epub ahead of print]

PMID:
28688623
12.

Management of hydrocephalus associated with autoimmune diseases: a series of 19 cases.

Ma B, Wu H, Yin H, Chang J, Wang L, Wang R, Ma W, Li Y, Guan J, Liu J, Wei J.

Autoimmunity. 2017 Jul 7:1-6. doi: 10.1080/08916934.2017.1344976. [Epub ahead of print]

PMID:
28686532
13.

[High blood pressure during the autonomic crises in children in intensive care unit: Etiologic circumstances and modality therapeutic].

Batouche DD, Benatta M, Okbani R, Benatta NF.

Ann Cardiol Angeiol (Paris). 2017 Jun;66(3):176-180. doi: 10.1016/j.ancard.2017.06.001. Epub 2017 Jul 3. French.

PMID:
28684012
14.

Guillain-Barré syndrome in association with antitumour necrosis factor therapy: a case of mistaken identity.

Patwala K, Crump N, De Cruz P.

BMJ Case Rep. 2017 Jul 5;2017. pii: bcr-2017-219481. doi: 10.1136/bcr-2017-219481.

PMID:
28679512
15.

Takotsubo cardiomyopathy with Guillain-Barré syndrome.

Gill D, Ruiz VG, Dean R, Liu K.

Proc (Bayl Univ Med Cent). 2017 Jul;30(3):307-308.

16.

Epigallocatechin gallate, an active green tea compound inhibits the Zika virus entry into host cells via binding the envelope protein.

Sharma N, Murali A, Singh SK, Giri R.

Int J Biol Macromol. 2017 Jun 28;104(Pt A):1046-1054. doi: 10.1016/j.ijbiomac.2017.06.105. [Epub ahead of print]

PMID:
28666829
17.

Effective Suckling C57BL/6, Kunming, and BALB/c Mouse Models with Remarkable Neurological Manifestation for Zika Virus Infection.

Yu J, Liu X, Ke C, Wu Q, Lu W, Qin Z, He X, Liu Y, Deng J, Xu S, Li Y, Zhu L, Wan C, Zhang Q, Xiao W, Xie Q, Zhang B, Zhao W.

Viruses. 2017 Jun 29;9(7). pii: E165. doi: 10.3390/v9070165.

18.

Things that could be Mycoplasma pneumoniae.

de Groot RCA, Meyer Sauteur PM, Unger WWJ, van Rossum AMC.

J Infect. 2017 Jun;74 Suppl 1:S95-S100. doi: 10.1016/S0163-4453(17)30198-6.

PMID:
28646969
19.

Global Alert: Zika Virus-an Emerging Arbovirus.

Ozkurt Z, Tanriverdi EC.

Eurasian J Med. 2017 Jun;49(2):142-147. doi: 10.5152/eurasianjmed.2017.17147. Review.

20.

RNA-dependent RNA polymerase: Addressing Zika outbreak by a phylogeny-based drug target study.

Stephen P, Lin SX.

Chem Biol Drug Des. 2017 Jun 21. doi: 10.1111/cbdd.13054. [Epub ahead of print]

PMID:
28636772

Supplemental Content

Loading ...
Support Center